$515.460
-12.165 (-2.36%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
UTHR Prediction & Forecast by Similar Chart Analysis
Alphio's UTHR stock price prediction model matches the current United Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $505.61 (-1.91%). The 1-week path is $490.77 (-4.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy United Therapeutics Corp Stock?
United Therapeutics Corp is currently priced at $515.46, which is close to the recent analyst price target of $516 from Morgan Stanley, indicating limited upside potential in the short term. The stock has a forward P/E of 19.19, suggesting it is fairly valued relative to its expected earnings growth. However, the company has shown strong revenue growth with a 1-year change of +27.33%, and the gross margin remains high at 87.30%, indicating solid profitability. The main risk is the RSI at 46.33, which suggests the stock is neither overbought nor oversold, indicating potential volatility ahead.
UTHR stock price ended at $515.46 on Friday, after losing -2.36%
United Therapeutics Corp (UTHR) last closed at $515.46, losing -2.36%. These facts feed the 1-day and 1-week UTHR price prediction above.
Analyst Consensus
United Therapeutics Corp (UTHR): 2 buy, 6 hold, 5 sell. Outlook: Sell.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
United Therapeutics Corp (UTHR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches UTHR, ranked by similarity.
Seasonality analysis for UTHR
Historically the probability of a positive August return for UTHR is 66.67%. September offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for UTHR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $378.39 | $408.54 | $409.02 | -20.74% |
| Sep 2026 | $400.69 | $415.84 | $474.31 | -19.33% |
| Oct 2026 | $367.94 | $404.09 | $458.71 | -21.61% |
| Nov 2026 | $341.08 | $357.40 | $360.53 | -30.66% |
| Dec 2026 | $399.83 | $429.48 | $447.75 | -16.68% |
In 2026, United Therapeutics Corp (UTHR) is projected to range from $341.08 to $474.31.
United Therapeutics Corp 2026 monthly forecast
In Aug 2026, United Therapeutics Corp is projected to average $408.54, with a low of $378.39 and high of $409.02.
In Sep 2026, United Therapeutics Corp is projected to average $415.84, with a low of $400.69 and high of $474.31.
In Oct 2026, United Therapeutics Corp is projected to average $404.09, with a low of $367.94 and high of $458.71.
In Nov 2026, United Therapeutics Corp is projected to average $357.40, with a low of $341.08 and high of $360.53.
In Dec 2026, United Therapeutics Corp is projected to average $429.48, with a low of $399.83 and high of $447.75.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.